📰 Platform Technology News
Page 20 - Platform Technology News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Platform Technology. Real-time updates on events, politics, business and more.
March 2, 2023
/PRNewswire/ -- Sinoveda has built its reputation on helping individuals deal with everyday aches and pains. Now, the innovative health brand will be taking...
February 24, 2023
/PRNewswire/ -- Proflexa is a natural topical pain reliever created by the innovative Canadian health brand Sinoveda. The cream is derived from a carefully...
February 24, 2023
/PRNewswire/ -- The world of healthcare is vast, intricate, and often divided. Each culture and geographic area tends to focus on viable yet different...
February 5, 2023
GSK is a leading pharmaceutical and consumer health care company with global reach. Meet the GlaxoSmithKline PLC leaders and executives here!
January 24, 2023
/PRNewswire/ -- The shift to parenthood can be intense. The mind, body, and soul must adjust to the sudden demand of being relied upon around the clock by...
January 24, 2023
/PRNewswire/ -- Soreness is a normal part of strenuous physical activity. It can develop during a workout, a pickup soccer game, a formally organized sport, or...
January 5, 2023
Total potential deal value up to $2 billion plus tiered royalties on commercial salesSynaffix to provide Amgen access to its proprietary antibody-drug conjugate (ADC) technologiesAMSTERDAM,
January 5, 2023
Automate with cloud ERP? Maybe. Personalize? Rarely seen. But all that and more is happening at Combilift. During a revealing session with the Combilift...
January 4, 2023
Synaffix to provide Hummingbird Bioscience access to proprietary ADC technologies Synaffix to receive up to $150m in upfront and milestone payments plus royalties SAN FRANCISCO, HOUSTON and SINGAPORE, Jan. 4, 2023 /PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, and Hummingbird Bioscience (Hummingbird Bio), a data-driven p...
January 4, 2023
Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program Synaffix to provide Hummingbird Bioscience access to proprietary ADC technologies Synaffix to receive up to $150m in upfront and milestone payments plus royalties   Amsterdam...